You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intrahepatic Biliary Tract Carcinoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Intrahepatic Cholangiocarcinoma, Gallbladder Cancer Trial (HAIC, Surufatinib, Tislelizumab)

Not yet recruiting
  • Carcinoma
  • +7 more
  • (no location specified)
Nov 12, 2023

Borderline Resectable Carcinoma, Biliary Tract Cancer Trial in Washington (Durvalumab, Tremelimumab, Gemcitabine)

Not yet recruiting
  • Borderline Resectable Carcinoma
  • Biliary Tract Cancer
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center, Georgetown University
Aug 24, 2023

Advanced Bile Duct Carcinoma, Advanced Gallbladder Carcinoma, Refractory Bile Duct Carcinoma Trial in Rochester (Irinotecan,

Active, not recruiting
Has Results
  • Advanced Bile Duct Carcinoma
  • +17 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 5, 2023

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting
  • Biliary Tract Cancer (CCA)
  • +4 more
  • Frankfurt am Main, Germany
    Krankenhaus Nordwest
Jun 23, 2022

Recurrent Biliary Tract Carcinoma, Recurrent Distal Bile Duct Adenocarcinoma, Recurrent Gallbladder Carcinoma Trial

Not yet recruiting
  • Recurrent Biliary Tract Carcinoma
  • +13 more
  • (no location specified)
Nov 8, 2022

Distal Bile Duct Adenocarcinoma, Gallbladder Carcinoma, Intrahepatic Cholangiocarcinoma Trial in Duarte (Cisplatin, Gemcitabine,

Suspended
  • Distal Bile Duct Adenocarcinoma
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Dec 8, 2022

Breast Cancer, Colon Cancer, Extrahepatic Bile Duct Cancer Trial in Duarte (procedure, other, drug)

Active, not recruiting
  • Breast Cancer
  • +11 more
  • radionuclide imaging
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Oct 20, 2022

Advanced Biliary Tract Cancer, Intrahepatic Cholangiocarcinoma, Extrahepatic Cholangiocarcinoma Trial in Hangzhou (Irinotecan

Not yet recruiting
  • Advanced Biliary Tract Cancer
  • +3 more
  • Irinotecan Liposome Injection
  • +3 more
  • Hangzhou, Zhejiang, China
    Cancer Hospital of the University of Chinese Academy of Sciences
Sep 16, 2021

Metastatic Distal Bile Duct Adenocarcinoma, Metastatic Gallbladder Carcinoma, Metastatic Intrahepatic Cholangiocarcinoma Trial

Recruiting
  • Metastatic Distal Bile Duct Adenocarcinoma
  • +9 more
  • Atezolizumab
  • +6 more
  • Phoenix, Arizona
  • +28 more
Dec 31, 2022

Intrahepatic Cholangiocarcinoma Trial in Germany (Durvalumab, Tremelimumab)

Recruiting
  • Intrahepatic Cholangiocarcinoma
  • Dresden, Germany
  • +7 more
Apr 13, 2022

Adenocarcinoma Metastatic, Biliary Tract Cancer, Adenocarcinoma of the Biliary Tract Trial in Ulm (Arm NaI-IRI + 5-FU +

Active, not recruiting
  • Adenocarcinoma Metastatic
  • +6 more
  • Arm NaI-IRI + 5-FU + Leucovorin (Arm A)
  • Arm Cisplatin + Gemcitabine (Arm B)
  • Ulm, Germany
    Universitätsklinikum Ulm
Apr 28, 2021

Biliary Tract Diseases, Gallbladder Cancer, Extrahepatic Bile Duct Cancer Trial (no interventions)

Not yet recruiting
  • Biliary Tract Diseases
  • +5 more
  • no interventions
  • (no location specified)
Jun 1, 2023

Biliary Tract Carcinoma Trial in Beijing (Gemcitabine, S1, Tislelizumab)

Not yet recruiting
  • Biliary Tract Carcinoma
  • Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Apr 10, 2023

Chromosomal Instability in Early Diagnosis of Biliary Tract

Recruiting
  • Biliary Tract Carcinoma
  • The extracted DNA from bile samples will be analyzed by BileCAD to determine the level of CIN.
  • Taizhou, Zhejiang, China
    Taizhou Hospital of Zhejiang Province
Apr 25, 2023

Biliary Tract Carcinoma Trial in Shanghai (Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab)

Recruiting
  • Biliary Tract Carcinoma
  • Combination of Gemcitabine, Oxaliplatin, Donafenib and Tislelizumab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 25, 2022

Biliary Tract Tumors Trial (Total Neoadjuvant Treatment)

Not yet recruiting
  • Biliary Tract Neoplasms
  • Total Neoadjuvant Treatment
  • (no location specified)
Sep 7, 2023

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Multi-Platform Profiling of Resected Biliary Tract Cancer

Recruiting
  • Biliary Tract Cancer
  • +7 more
  • Multi-Platform Profiling with Organoid Drug Sensitivity Screening and ctDNA Monitoring
  • Chicago, Illinois
  • +1 more
Jan 23, 2023

HER2-positive Colorectal Cancer, HER2-positive Biliary Tract Cancer Trial in Beijing (KN026, KN046, XELOX)

Not yet recruiting
  • HER2-positive Colorectal Cancer
  • HER2-positive Biliary Tract Cancer
  • Beijing, State*, China
    Peking University cancer hospital & institution
Aug 2, 2023

Biliary Tract Cancer Trial in Changchun (Lenvatinib, PD-1 inhibitors)

Recruiting
  • Biliary Tract Cancer
  • Changchun, Jilin, China
    Liu Bo
Aug 18, 2022

Incidental Gallbladder Carcinoma-Permanent Platform Including

Recruiting
  • Biliary Tract Cancer
  • Neoadjuvant, Adjuvant and 1st Line
    • Frankfurt, Germany
      Krankenhaus Nordwest GmbH
    Aug 3, 2022

    Biliary Tract Carcinoma, Cholangiocarcinoma, Bile Duct Cancer Trial in Madison (Gemcitabine, Cisplatin, Zimberelimab)

    Not yet recruiting
    • Biliary Tract Carcinoma
    • +2 more
    • Madison, Wisconsin
      University of Wisconsin
    Sep 15, 2023

    Biliary Tract Carcinoma, Biliary Obstruction Trial in Brno (Cryobiopsy catheter)

    Recruiting
    • Biliary Tract Carcinoma
    • Biliary Obstruction
    • Cryobiopsy catheter
    • Brno, Czechia
      Brno University Hospital
    Sep 19, 2023

    Hepatocellular Cancer, Hepatocellular Carcinoma, Metastatic Hepatocellular Carcinoma Trial run by the NCI (durvalumab,

    Recruiting
    • Hepatocellular Cancer
    • +2 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Hepatocellular Carcinoma, Pancreatic Ductal Adenocarcinoma, Biliary Tract Cancers Trial (ABBV-400)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • +6 more
    • (no location specified)
    Oct 10, 2023